Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 168 | 5 | 163 | 0 |
| Shares | 75.9M | 472.5K | 78.3M | +2.86M (+3.8%) |
| Value | $1.49B | $9.96M | $1.34B | −$135.3M (−9.2%) |
5 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 306,062 | $5.24M | 0.06% |
| Sphera Funds Management Ltd. | 236,000 | $4.04M | 0.88% |
| Jefferies Financial Group Inc. | 235,316 | $4.03M | 0.09% |
| Qube Research & Technologies Ltd | 98,649 | $1.69M | 0.01% |
| Rice Hall James & Associates, LLC | 75,675 | $1.30M | 0.07% |
| Profund Advisors LLC | 55,516 | $951.0K | 0.06% |
| Jump Financial, LLC | 44,278 | $758.5K | 0.03% |
| Victory Capital Management Inc | 39,650 | $679.2K | 0.00% |
| Harvest Investment Services, LLC | 26,684 | $457.1K | 0.35% |
| Occudo Quantitative Strategies LP | 23,487 | $402.3K | 0.04% |
| LPL Financial LLC | 13,241 | $226.8K | 0.00% |
| NinePointTwo Capital | 11,936 | $204.0K | 0.08% |
| EFG Asset Management (Americas) Corp. | 10,882 | $186.4K | 0.04% |
| Dark Forest Capital Management LP | 4,790 | $82.1K | 0.02% |
| Simplex Trading, LLC | 3,385 | $57.0K | 0.00% |
| Clearstead Advisors, LLC | 1,840 | $31.5K | 0.00% |
| Values First Advisors, Inc. | 1 | $9 | 0.00% |
Sold out (17)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Tiger Management L.L.C. | 279,700 | $5.47M |
| Affinity Asset Advisors, LLC | 258,115 | $5.05M |
| Granite Point Capital Management, L.P. | 140,000 | $2.74M |
| Caption Management, LLC | 130,000 | $2.54M |
| Ally Bridge Group (NY) LLC | 125,176 | $2.45M |
| Healthcare of Ontario Pension Plan Trust Fund | 82,000 | $1.60M |
| Schonfeld Strategic Advisors LLC | 51,024 | $998.5K |
| Algert Global LLC | 49,768 | $974.0K |
| New York Life Investment Management LLC | 35,766 | $699.9K |
| Prosight Management, LP | 32,193 | $630.0K |
| Sanders Morris Harris LLC | 27,709 | $542.3K |
| XTX Topco Ltd | 19,859 | $388.6K |
| Marshall Wace, LLP | 13,500 | $264.2K |
| Squarepoint Ops LLC | 12,201 | $238.8K |
| Clear Harbor Asset Management, LLC | 10,160 | $198.8K |
| Balyasny Asset Management LLC | 542 | $10.6K |
| Centennial Bank | 500 | $9.79K |
Not filed for Q1 2023 yet (5)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 288,316 | $6.36M |
| Monarch Partners Asset Management LLC | 113,788 | $2.23M |
| HealthCor Management, L.P. | 50,000 | $978.5K |
| Alpha Paradigm Partners, LLC | 20,165 | $395.0K |
| Heritage Wealth Management, LLC | 200 | $3.91K |